Literature DB >> 9353509

Recent advances in endocrine therapy of breast cancer.

A Howell1, M Dowsett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353509      PMCID: PMC2127570          DOI: 10.1136/bmj.315.7112.863

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  11 in total

Review 1.  Tamoxifen resistance in breast cancer: elucidating mechanisms.

Authors:  L C Dorssers; S Van der Flier; A Brinkman; T van Agthoven; J Veldscholte; E M Berns; J G Klijn; L V Beex; J A Foekens
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Adjuvant Endocrine Therapy in Premenopausal Patients.

Authors:  Michael Gnant
Journal:  Breast Care (Basel)       Date:  2008-10-17       Impact factor: 2.860

3.  Preparation and Characterization of Chitosan and Inclusive Compound-Layered Gold Nanocarrier to Improve the Antiproliferation Effect of Tamoxifen Citrate in Colorectal Adenocarcinoma (Caco-2) and Breast Cancer (MCF-7) Cells.

Authors:  Yahia Kahlous; Vijayaraj Kumar Palanirajan; Melbha Starlin; Jeetendra Singh Negi; Shiau-Chuen Cheah
Journal:  Turk J Pharm Sci       Date:  2022-08-31

4.  Trends in 1-year survival of people admitted to hospital in Ontario, 1994-2009.

Authors:  Carl van Walraven
Journal:  CMAJ       Date:  2013-09-30       Impact factor: 8.262

Review 5.  Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.

Authors:  Lorna Gibson; David Lawrence; Claire Dawson; Judith Bliss
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

6.  Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study.

Authors:  Katja Lundgren; Matthew Brown; Silvia Pineda; Jack Cuzick; Janine Salter; Lila Zabaglo; Anthony Howell; Mitch Dowsett; Göran Landberg
Journal:  Breast Cancer Res       Date:  2012-04-04       Impact factor: 6.466

7.  Has tamoxifen had its day?

Authors:  Michael Baum
Journal:  Breast Cancer Res       Date:  2002-08-27       Impact factor: 6.466

8.  Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex and tamoxifen alone or in combination' (ATAC) trial.

Authors:  M Dowsett; J Cuzick; A Howell; I Jackson
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

9.  The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer.

Authors:  M Dowsett; J S Tobias; A Howell; G M Blackman; H Welch; N King; R Ponzone; M von Euler; M Baum
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

10.  Exostosin 1 regulates cancer cell stemness in doxorubicin-resistant breast cancer cells.

Authors:  Sarala Manandhar; Chang-Gu Kim; Sun-Hee Lee; Soo Hyun Kang; Nikita Basnet; You Mie Lee
Journal:  Oncotarget       Date:  2017-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.